DK3551633T3 - Substituerede pyrazoloazepin-4-oner og anvendelse deraf som phosphodiesterasehæmmere - Google Patents
Substituerede pyrazoloazepin-4-oner og anvendelse deraf som phosphodiesterasehæmmere Download PDFInfo
- Publication number
- DK3551633T3 DK3551633T3 DK16809388.8T DK16809388T DK3551633T3 DK 3551633 T3 DK3551633 T3 DK 3551633T3 DK 16809388 T DK16809388 T DK 16809388T DK 3551633 T3 DK3551633 T3 DK 3551633T3
- Authority
- DK
- Denmark
- Prior art keywords
- ones
- phosphodiesterase inhibitors
- pyrazoloazepin
- substituted
- substituted pyrazoloazepin
- Prior art date
Links
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 title 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2016/080548 WO2018108230A1 (en) | 2016-12-12 | 2016-12-12 | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3551633T3 true DK3551633T3 (da) | 2021-06-28 |
Family
ID=57539258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16809388.8T DK3551633T3 (da) | 2016-12-12 | 2016-12-12 | Substituerede pyrazoloazepin-4-oner og anvendelse deraf som phosphodiesterasehæmmere |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10906915B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3551633B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6850886B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110088108B (cg-RX-API-DMAC7.html) |
| DK (1) | DK3551633T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2875128T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2762279C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018108230A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11065257B2 (en) * | 2016-12-12 | 2021-07-20 | Leo Pharma A/S | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
| AU2018286964B2 (en) | 2017-06-20 | 2022-04-14 | UNION therapeutics A/S | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
| WO2019115776A1 (en) | 2017-12-15 | 2019-06-20 | Leo Pharma A/S | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors |
| GB202306662D0 (en) | 2023-05-05 | 2023-06-21 | Union Therapeutics As | Dosage regimen |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2803299B1 (fr) * | 2000-01-05 | 2004-09-17 | Warner Lambert Co | NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
| US7423031B2 (en) | 2003-05-01 | 2008-09-09 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| AR058071A1 (es) * | 2005-10-03 | 2008-01-23 | Astrazeneca Ab | Derivados de dihidropirazolo (3,4-e)(1,4)diazepina. procesos de obtencion y composiciones farmaceuticas. |
| CA2669886A1 (en) | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
| PL2114951T3 (pl) * | 2007-02-28 | 2014-10-31 | Leo Pharma As | Nowe inhibitory fosfodiesterazy |
| GB0704652D0 (en) | 2007-03-09 | 2007-04-18 | Syngenta Participations Ag | Novel herbicides |
| AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
-
2016
- 2016-12-12 CN CN201680091502.7A patent/CN110088108B/zh not_active Expired - Fee Related
- 2016-12-12 RU RU2019121006A patent/RU2762279C2/ru active
- 2016-12-12 ES ES16809388T patent/ES2875128T3/es active Active
- 2016-12-12 US US16/468,420 patent/US10906915B2/en active Active
- 2016-12-12 JP JP2019531209A patent/JP6850886B2/ja not_active Expired - Fee Related
- 2016-12-12 WO PCT/EP2016/080548 patent/WO2018108230A1/en not_active Ceased
- 2016-12-12 EP EP16809388.8A patent/EP3551633B1/en active Active
- 2016-12-12 DK DK16809388.8T patent/DK3551633T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019121006A3 (cg-RX-API-DMAC7.html) | 2021-01-12 |
| US10906915B2 (en) | 2021-02-02 |
| ES2875128T3 (es) | 2021-11-08 |
| US20200010477A1 (en) | 2020-01-09 |
| JP6850886B2 (ja) | 2021-03-31 |
| EP3551633A1 (en) | 2019-10-16 |
| CN110088108B (zh) | 2024-06-14 |
| JP2020500920A (ja) | 2020-01-16 |
| EP3551633B1 (en) | 2021-03-31 |
| WO2018108230A1 (en) | 2018-06-21 |
| RU2762279C2 (ru) | 2021-12-17 |
| CN110088108A (zh) | 2019-08-02 |
| RU2019121006A (ru) | 2021-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269196A (en) | Novel inhibitors | |
| DK3277681T3 (da) | Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer | |
| IL263586A (en) | Inhibitors of the menin-mll interaction | |
| IL280863A (en) | Autotaxin inhibitors and uses thereof | |
| EP3541932A4 (en) | INHIBITORS OF CRISPR-CAS9 | |
| DK3389658T3 (da) | Glycosidasehæmmere og anvendelser deraf | |
| DK3149001T3 (da) | Hidtil ukendte pyrazolopyrimidinderivater og deres anvendelse som MALT1-hæmmere | |
| DK3442972T3 (da) | Bromdomænehæmmere | |
| DK3310784T3 (da) | Tricykliske forbindelser og deres anvendelse som phosphodiesterasehæmmere | |
| DK3663290T3 (da) | Polymethinforbindelser og anvendelse deraf som fluorescerende markører | |
| DK3571192T3 (da) | Jak1-selektive inhibitorer | |
| DK3221306T3 (da) | Heteroarylforbindelser som irak-inhibitorer og anvendelser deraf | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3233863T3 (da) | Kondenserede ringheteroarylforbindelser og anvendelse deraf som trk-hæmmere | |
| DK3538528T3 (da) | Pyrrolamider som alpha v-integrinhæmmere | |
| DK3543240T3 (da) | URAT1-inhibitor og anvendelse deraf | |
| DK3313833T3 (da) | Forbindelser og anvendelse deraf som inhibitorer af n-myristoyl-transferase | |
| DK3341379T3 (da) | EZH2-hæmmere | |
| DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
| DK3621694T5 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
| DK3724196T3 (da) | Substituerede azetidindihydrothienopyridiner og anvendelse deraf som phosphodiesterasehæmmere | |
| DK3321279T3 (da) | Exenatidmodificeringsmiddel og anvendelse deraf | |
| EP3600301A4 (en) | KDM4 INHIBITORS | |
| EP3615525C0 (en) | PYRROLE DERIVATIVES AS PLK1 INHIBITORS |